Skip to main content

AI

By Dave Muoio | 06:34 pm | April 30, 2018
Fitbit and Google have entered a partnership focused on better leveraging wearables and cloud-based technologies for digital health, the companies announced this morning.
By Mike Miliard | 10:13 am | April 30, 2018
At AcademyHealth’s 2018 Health Datapalooza on Thursday, the US Food and Drug Administration offered a vote of confidence for artificial intelligence in healthcare, promising more refined strategies for regulation, touting its tech incubator for AI innovation, and announcing a new machine learning partnership with Harvard.
By Laura Lovett | 12:10 pm | April 26, 2018
This morning healthcare AI company Qure.
By Laura Lovett | 04:56 pm | April 25, 2018
The name Nvidia usually creates a synapse to the video game industry — or more recently the self-driving car business.
By Laura Lovett | 02:13 pm | April 25, 2018
Like almost any field in the healthcare industry pharma wants to get in on the latest technology trends.
By Dave Muoio | 04:45 pm | April 20, 2018
Data published in Scientific Reports describes an algorithm that allows users to measure a patient’s pulse wave velocity using the camera on a smartphone.
By Jonah Comstock | 02:03 pm | April 20, 2018
BenevolentAI, a UK company using artificial intelligence for drug development, has raised $115 million in new funding, mostly from undisclosed investors in the United States.
By Leontina Postelnicu | 04:52 pm | April 16, 2018
HIMSS UK Executive Leadership Summit panel assesses the potential of the NHS to deploy AI technologies considering the current state of its infrastructure.
By Leontina Postelnicu | 01:29 pm | April 16, 2018
The House of Lords Select Committee on Artificial Intelligence urges the NHS to digitise its 'current practices and records' by 2022 and sets out a series of recommendations to support sensible adoption of new technologies.
By Dave Muoio | 12:10 pm | April 12, 2018
The FDA has granted diagnostics company IDx’s De Novo request to market its AI-based software system for the autonomous detection of diabetic retinopathy in adults who have diabetes, called IDx-DR.